Dr. Reddy's Laboratories Limited Missed Consensus Estimates

Dr. Reddy's Laboratories Limited (RDY) reported earnings of $0.12 per share on revenue of $905.00 million for the fiscal second quarter ended September 2026. The consensus earnings estimate was $0.16 per share on revenue of $980.65 million. The company missed consensus estimates by 25.00% while revenue fell 8.77% compared to the same quarter a year ago.

Dr Reddy Laboratories Ltd together with its subsidiaries is engaged in manufacturing of pharmaceutical products. It operates through three segments; Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products.